Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
23.45
+0.55 (2.40%)
Jun 29, 2026, 10:24 AM EDT - Market open
Nurix Therapeutics Employees
Nurix Therapeutics had 317 employees as of November 30, 2025. The number of employees increased by 31 or 10.84% compared to the previous year.
Employees
317
Change (1Y)
31
Growth (1Y)
10.84%
Revenue / Employee
$226,432
Profits / Employee
-$931,483
Market Cap
2.42B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Nov 30, 2025 | 317 | 31 | 10.84% |
| Nov 30, 2024 | 286 | 2 | 0.70% |
| Nov 30, 2023 | 284 | -13 | -4.38% |
| Nov 30, 2022 | 297 | 55 | 22.73% |
| Nov 30, 2021 | 242 | 107 | 79.26% |
| Nov 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Agios Pharmaceuticals | 540 |
| Vericel | 398 |
| Intellia Therapeutics | 377 |
| Biohaven | 274 |
| Immunome | 206 |
| Pharvaris | 134 |
| Kodiak Sciences | 130 |
NRIX News
- 2 hours ago - Nurix Therapeutics assumed with an Outperform at Oppenheimer - TheFly
- 11 days ago - Nurix Therapeutics price target raised to $33 from $26 at Baird - TheFly
- 18 days ago - Nurix Therapeutics to Report Updated Phase 1a/b Results for BTK Degrader Bexobrutideg, Highlighting Durable Responses in Relapsed/Refractory CLL/SLL and Promising Activity in Earlier Lines of Therapy - GlobeNewsWire
- 20 days ago - Nurix Therapeutics price target raised to $32 from $30 at Truist - TheFly
- 20 days ago - Nurix Therapeutics price target raised to $32 from $30 at BTIG - TheFly
- 20 days ago - Nurix Therapeutics price target raised to $32 from $30 at Truist - TheFly
- 20 days ago - Nurix Therapeutics price target raised to $45 from $41 at Jefferies - TheFly
- 21 days ago - Nurix Therapeutics price target raised to $34 from $26 at Needham - TheFly